After weeks of internal disagreements at the Federal Trade Commission about pharmacy benefit managers, the agency said Sept. 20 that it is suing CVS Caremark, Optum Rx and Express Scripts over allegedly inflating insulin prices.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
